METHODS OF TREATING CANCER WITH TUBULYSIN CONJUGATES
申请人:Endocyte, Inc.
公开号:US20170290878A1
公开(公告)日:2017-10-12
The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. The invention described herein also relates to methods of treating folate-expressing cancers with a folate tubulysin conjugate in patients where stable disease results after treatment with the folate-tubulysin conjugate.